Medical Condition News

RSS

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.

21 Sep 2018

TINY cancer detection device shows promise as point-of-care detector of KSHV

Its name is an acronym used to convey its size, but researchers at Cornell Engineering and Weill Cornell Medicine are hoping their hand-held cancer detection device's impact in the developing world is anything but small.

21 Sep 2018

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel.

21 Sep 2018

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

Non-steroidal anti-inflammatory drugs, or NSAIDs, are commonly used as inflammation blockers worldwide. However, recent clinical data show these painkillers can have serious side effects that create some risk of heart attacks, strokes, and kidney or heart failure.

21 Sep 2018

New research finds that MHC-II molecules have more influence on tumors than MHC-I

Cancer immunotherapy -- efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own -- has shown great promise for some previously intractable cancers.

21 Sep 2018

Study reveals promising new drug candidate to treat acute renal failure

A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University in São José do Rio Preto, Brazil.

20 Sep 2018

Immediate compression therapy could cut risk of complications after deep-vein thrombosis

People with deep-vein thrombosis can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy in the first twenty-four hours of DVT therapy (known as the acute phase of treatment), suggests a study published today in the journal Blood.

20 Sep 2018

Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness

In a comprehensive study, researchers from Aarhus University show that grieving patients who receive what is known as talk therapy at the general practitioner shortly after a relative's death, have a lower risk of suicide and psychiatric illness than others.

20 Sep 2018

Brain region for stress control is enlarged in people with depression, finds study

According to the World Health Organization, 322 million people worldwide were affected by depression in 2015--4.4 percent of the world's population.

20 Sep 2018

First evaluation of benefits, harms of Alzheimer's screening for family members of older adults

With the support of a new $3 million, five-year National Institute on Aging grant, researchers from the Regenstrief Institute and Indiana University Center for Aging Research are conducting the first evaluation of the benefits and harms of Alzheimer's disease screening for family members of older adults.

20 Sep 2018

Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes

Researchers at Case Western Reserve University have discovered how to quickly and accurately predict which lung cancer patients will benefit from chemotherapy by analyzing how immune cells the body sends out to fight the disease are arranged.

20 Sep 2018

CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer

Certain genes that code for proteins have long been known to contribute to cancer progression. But in a frame shift, researchers from Case Western Reserve University School of Medicine recently found that non-coding genes also contribute to the development and spreading of the disease, one of the first known examples of researchers doing so.

20 Sep 2018

New type of fatty acid can slow down overreactive immune system

Sometimes, the body's otherwise intelligent immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist.

20 Sep 2018

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

With an estimated 1.6 million people in the U.S. dealing with inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective.

20 Sep 2018

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

20 Sep 2018

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data during a poster session at the Global Congress on Bladder Cancer 2018.

20 Sep 2018

New program to reduce harmful stress effectively improves mood in cancer patients

This is a story about something rare in health psychology: a treatment that has gone from scientific discovery, through development and testing, to dissemination and successful implementation nationwide.

20 Sep 2018

Chaos and agitation: Helping a patient survive a hurricane

As Hurricane Florence barreled toward her coastal community, Patty Younts grappled with a question: Where should a person with dementia go?

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

Survey: 91% of people around the world believe medical research will result in dementia cure

A new survey from Novartis, Amgen and Banner Alzheimer’s Institute, along with Alzheimer’s Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.

20 Sep 2018

Medical Condition News

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

TINY cancer detection device shows promise as point-of-care detector of KSHV

Dopamine neurons may involve in conditions ranging from Parkinson's disease to schizophrenia

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

New research finds that MHC-II molecules have more influence on tumors than MHC-I

Study reveals promising new drug candidate to treat acute renal failure

Immediate compression therapy could cut risk of complications after deep-vein thrombosis

Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness

Brain region for stress control is enlarged in people with depression, finds study

First evaluation of benefits, harms of Alzheimer's screening for family members of older adults

Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes

CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer

New type of fatty acid can slow down overreactive immune system

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

New program to reduce harmful stress effectively improves mood in cancer patients

Chaos and agitation: Helping a patient survive a hurricane

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Survey: 91% of people around the world believe medical research will result in dementia cure

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News